Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Anti-Bacterial Agents / pharmacology
• Anti-Bacterial Agents / therapeutic use*
• Bacteremia / drug therapy*
• Bacteremia / microbiology
• Case-Control Studies
• Drug Resistance, Bacterial*
• Enterobacteriaceae / drug effects
• Enterobacteriaceae / enzymology
• Enterobacteriaceae Infections / drug therapy
• Enterobacteriaceae Infections / microbiology
• Ertapenem
• Escherichia coli / drug effects*
• Escherichia coli / enzymology
• Female
• Humans
• Klebsiella pneumoniae / drug effects*
• Klebsiella pneumoniae / enzymology
• Male
• Meropenem
• Microbial Sensitivity Tests
• Middle Aged
• Risk Factors
• Thienamycins / pharmacology
• Thienamycins / therapeutic use
• Treatment Outcome
• beta-Lactams / pharmacology
• beta-Lactams / therapeutic use*